Becker's Healthcare September 19, 2024
BioAge Labs, a clinical-stage biotech firm focused on obesity and metabolic disease therapies, aims to raise up to $157.5 million through its initial public offering and private placement, Bloomberg reported Sept. 18.
The company plans to offer 7.5 million shares priced between $17 and $19 each,...